GLIOMAS
Clinical trials for GLIOMAS explained in plain language.
Never miss a new study
Get alerted when new GLIOMAS trials appear
Sign up with your email to follow new studies for GLIOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain tumor drug vorasidenib tested in everyday practice
Disease control OngoingThis study looks at how well the drug vorasidenib works and how safe it is for people with a slow-growing type of brain tumor called grade 2 astrocytoma or oligodendroglioma that has an IDH1 or IDH2 mutation. The study includes people aged 12 and older in China who are treated in…
Matched conditions: GLIOMAS
Phase: NA • Sponsor: Servier (Tianjin) Pharmaceutical Co. LTD. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New PET scan could slash radiation by 100x
Diagnosis ENROLLING_BY_INVITATIONThis study tests a new PET imaging technique that uses 10 to 100 times less radiation than standard scans. Researchers will inject 200 healthy volunteers and patients with a radioactive tracer and use a high-sensitivity scanner to see if image quality remains good enough for dete…
Matched conditions: GLIOMAS
Phase: PHASE2 • Sponsor: Akiva Mintz • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Scientists watch brain tumors transform using advanced imaging
Knowledge-focused TerminatedThis study tracks a substance called 2-HG in the brains of people with a type of brain cancer (glioma) that has specific gene changes. By using special MRI scans over time, researchers hope to learn how and when these tumors become more aggressive. About 42 adults will have regul…
Matched conditions: GLIOMAS
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC